[Efficacy of prolonged therapy with vitamins C and A and radiologic changes in the Ehlers-Danlos syndrome]
Related Experiment Videos
Insights
This seven-year study tracked two children with Ehlers-Danlos syndrome. Treatment with vitamins, mineral waters, and kinesitherapy showed potential benefits compared to the untreated child.
Area of Science:
- Pediatrics
- Genetics
- Rheumatology
Background:
- Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders.
- EDS can lead to joint hypermobility, skin hyperextensibility, and tissue fragility.
- Understanding long-term progression and treatment efficacy in pediatric EDS is crucial.
Observation:
- Two similarly-aged children with EDS were monitored over seven years.
- One child received a comprehensive treatment regimen including vitamins C and A, Lipovitan, mineral waters, and kinesitherapy.
- The other child served as a control, receiving no specific treatment.
Findings:
- The study aimed to evaluate the efficacy of the administered therapy in the treated child.
- It also focused on documenting progressive osseous changes in the non-treated control child.
- This comparative approach allows for assessing treatment impact on EDS progression.
Implications:
- Findings may inform therapeutic strategies for pediatric Ehlers-Danlos syndrome.
- The study highlights the importance of long-term follow-up in managing rare genetic disorders.
- Results could guide future research into optimizing supportive care for EDS patients.
Abstract:
Two children of the same sex, almost of equal age, and suffering from the Ehlers-Danlos syndrome were followed up for a period of seven years. One of the children was subjected to a systematic treatment with vitamins C and A, Lipovitan, sulphuric mineral waters, and kinesitherapy. The non-treated child is serving as control person for the treated one. Thus it has been possible to evaluate the efficacy of the therapy administered to the first child and also to state the osseous progressive changes in the non-treated child.